vs
CANTALOUPE, INC.（CTLP）与帕可Bio（PACB）财务数据对比。点击上方公司名可切换其他公司
CANTALOUPE, INC.的季度营收约是帕可Bio的1.8倍（$78.7M vs $44.6M），CANTALOUPE, INC.净利率更高（-0.1% vs -90.4%，领先90.3%），帕可Bio同比增速更快（13.8% vs 6.8%），CANTALOUPE, INC.自由现金流更多（$-614.0K vs $-19.9M），过去两年CANTALOUPE, INC.的营收复合增速更高（7.7% vs 7.3%）
坎塔卢波（原美国技术公司）是一家美国科技企业，核心业务为ePort无现金支付受理技术，依托持专利的PCI合规ePort Connect服务开展运营。该服务可通过无线方式为消费者提供信用卡、借记卡以及Apple Pay、Google Pay等NFC钱包支付选项，同时为运营商提供遥测与机器间通信服务，ePort技术主要应用于...
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
CTLP vs PACB — 直观对比
营收规模更大
CTLP
是对方的1.8倍
$44.6M
营收增速更快
PACB
高出7.1%
6.8%
净利率更高
CTLP
高出90.3%
-90.4%
自由现金流更多
CTLP
多$19.3M
$-19.9M
两年增速更快
CTLP
近两年复合增速
7.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $78.7M | $44.6M |
| 净利润 | $-70.0K | $-40.4M |
| 毛利率 | — | 37.1% |
| 营业利润率 | 2.0% | -92.3% |
| 净利率 | -0.1% | -90.4% |
| 营收同比 | 6.8% | 13.8% |
| 净利润同比 | -101.4% | -1802.7% |
| 每股收益（稀释后） | $0.00 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTLPPACB
| Q4 25 | $78.7M | $44.6M | ||
| Q3 25 | $80.9M | $38.4M | ||
| Q2 25 | $82.6M | $39.8M | ||
| Q1 25 | $75.4M | $37.2M | ||
| Q4 24 | $73.7M | $39.2M | ||
| Q3 24 | $70.8M | $40.0M | ||
| Q2 24 | $72.7M | $36.0M | ||
| Q1 24 | $67.9M | $38.8M |
净利润CTLPPACB
| Q4 25 | $-70.0K | $-40.4M | ||
| Q3 25 | $-919.0K | $-38.0M | ||
| Q2 25 | $6.8M | $-41.9M | ||
| Q1 25 | $49.2M | $-426.1M | ||
| Q4 24 | $5.0M | $2.4M | ||
| Q3 24 | $3.6M | $-60.7M | ||
| Q2 24 | $2.2M | $-173.3M | ||
| Q1 24 | $4.7M | $-78.2M |
毛利率CTLPPACB
| Q4 25 | — | 37.1% | ||
| Q3 25 | — | 41.4% | ||
| Q2 25 | — | 36.9% | ||
| Q1 25 | — | -3.7% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 25.0% | ||
| Q2 24 | — | 16.5% | ||
| Q1 24 | 39.6% | 29.1% |
营业利润率CTLPPACB
| Q4 25 | 2.0% | -92.3% | ||
| Q3 25 | 2.0% | -101.1% | ||
| Q2 25 | 6.3% | -112.8% | ||
| Q1 25 | 9.1% | -1154.5% | ||
| Q4 24 | 8.4% | -390.1% | ||
| Q3 24 | 5.8% | -160.3% | ||
| Q2 24 | 4.9% | -488.3% | ||
| Q1 24 | 6.3% | -209.6% |
净利率CTLPPACB
| Q4 25 | -0.1% | -90.4% | ||
| Q3 25 | -1.1% | -98.9% | ||
| Q2 25 | 8.3% | -105.4% | ||
| Q1 25 | 65.2% | -1146.8% | ||
| Q4 24 | 6.7% | 6.0% | ||
| Q3 24 | 5.0% | -151.9% | ||
| Q2 24 | 3.0% | -481.3% | ||
| Q1 24 | 6.9% | -201.4% |
每股收益（稀释后）CTLPPACB
| Q4 25 | $0.00 | $-0.11 | ||
| Q3 25 | $-0.02 | $-0.13 | ||
| Q2 25 | $0.10 | $-0.14 | ||
| Q1 25 | $0.65 | $-1.44 | ||
| Q4 24 | $0.07 | $-0.44 | ||
| Q3 24 | $0.04 | $-0.22 | ||
| Q2 24 | $0.03 | $-0.64 | ||
| Q1 24 | $0.06 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $53.0M | $279.5M |
| 总债务越低越好 | $37.7M | — |
| 股东权益账面价值 | $252.5M | $5.3M |
| 总资产 | $381.9M | $784.1M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资CTLPPACB
| Q4 25 | $53.0M | $279.5M | ||
| Q3 25 | $55.0M | $298.7M | ||
| Q2 25 | $51.1M | $314.7M | ||
| Q1 25 | $46.3M | $343.1M | ||
| Q4 24 | $27.7M | $389.9M | ||
| Q3 24 | $33.1M | $471.1M | ||
| Q2 24 | $58.9M | $509.8M | ||
| Q1 24 | $50.2M | $561.9M |
总债务CTLPPACB
| Q4 25 | $37.7M | — | ||
| Q3 25 | $38.3M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $39.2M | — | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $37.3M | — | ||
| Q2 24 | $37.5M | — | ||
| Q1 24 | $38.1M | — |
股东权益CTLPPACB
| Q4 25 | $252.5M | $5.3M | ||
| Q3 25 | $251.8M | $36.1M | ||
| Q2 25 | $251.0M | $61.5M | ||
| Q1 25 | $240.7M | $91.6M | ||
| Q4 24 | $190.1M | $506.6M | ||
| Q3 24 | $186.2M | $453.1M | ||
| Q2 24 | $181.7M | $492.7M | ||
| Q1 24 | $178.8M | $649.0M |
总资产CTLPPACB
| Q4 25 | $381.9M | $784.1M | ||
| Q3 25 | $389.5M | $803.2M | ||
| Q2 25 | $381.9M | $825.5M | ||
| Q1 25 | $370.5M | $860.8M | ||
| Q4 24 | $303.0M | $1.3B | ||
| Q3 24 | $312.1M | $1.5B | ||
| Q2 24 | $335.6M | $1.5B | ||
| Q1 24 | $319.9M | $1.7B |
负债/权益比CTLPPACB
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.16× | — | ||
| Q4 24 | 0.19× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.1M | $-19.1M |
| 自由现金流经营现金流 - 资本支出 | $-614.0K | $-19.9M |
| 自由现金流率自由现金流/营收 | -0.8% | -44.6% |
| 资本支出强度资本支出/营收 | 4.8% | 1.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $25.8M | $-114.1M |
8季度趋势，按日历期对齐
经营现金流CTLPPACB
| Q4 25 | $3.1M | $-19.1M | ||
| Q3 25 | $7.0M | $-18.7M | ||
| Q2 25 | $9.4M | $-29.4M | ||
| Q1 25 | $22.4M | $-44.1M | ||
| Q4 24 | $522.0K | $-30.6M | ||
| Q3 24 | $-12.0M | $-45.5M | ||
| Q2 24 | $14.3M | $-54.3M | ||
| Q1 24 | $14.7M | $-75.7M |
自由现金流CTLPPACB
| Q4 25 | $-614.0K | $-19.9M | ||
| Q3 25 | $3.5M | $-18.8M | ||
| Q2 25 | $4.3M | $-29.9M | ||
| Q1 25 | $18.6M | $-45.4M | ||
| Q4 24 | $-3.8M | $-32.3M | ||
| Q3 24 | $-15.8M | $-46.3M | ||
| Q2 24 | $8.5M | $-55.7M | ||
| Q1 24 | $11.4M | $-79.6M |
自由现金流率CTLPPACB
| Q4 25 | -0.8% | -44.6% | ||
| Q3 25 | 4.4% | -48.9% | ||
| Q2 25 | 5.3% | -75.3% | ||
| Q1 25 | 24.6% | -122.3% | ||
| Q4 24 | -5.1% | -82.3% | ||
| Q3 24 | -22.3% | -115.7% | ||
| Q2 24 | 11.7% | -154.8% | ||
| Q1 24 | 16.9% | -205.0% |
资本支出强度CTLPPACB
| Q4 25 | 4.8% | 1.9% | ||
| Q3 25 | 4.2% | 0.2% | ||
| Q2 25 | 6.2% | 1.4% | ||
| Q1 25 | 5.1% | 3.7% | ||
| Q4 24 | 5.8% | 4.1% | ||
| Q3 24 | 5.4% | 2.0% | ||
| Q2 24 | 7.9% | 4.1% | ||
| Q1 24 | 4.8% | 10.0% |
现金转化率CTLPPACB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.38× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 0.10× | -12.93× | ||
| Q3 24 | -3.36× | — | ||
| Q2 24 | 6.47× | — | ||
| Q1 24 | 3.16× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTLP
| Transaction Processing | $47.9M | 61% |
| Subscription Revenue | $21.8M | 28% |
| Products | $9.0M | 11% |
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
